3-122103665-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_175862.5(CD86):āc.218A>Gā(p.Glu73Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E73Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_175862.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CD86 | NM_175862.5 | c.218A>G | p.Glu73Gly | missense_variant | 3/7 | ENST00000330540.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CD86 | ENST00000330540.7 | c.218A>G | p.Glu73Gly | missense_variant | 3/7 | 1 | NM_175862.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251280Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135804
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461772Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727190
GnomAD4 genome AF: 0.000236 AC: 36AN: 152330Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74492
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.200A>G (p.E67G) alteration is located in exon 3 (coding exon 2) of the CD86 gene. This alteration results from a A to G substitution at nucleotide position 200, causing the glutamic acid (E) at amino acid position 67 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at